- Home
- RARE vs OSW Comparison
RARE vs OSW Comparison
Compare RARE & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | OSW |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | Bahamas |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | RARE | OSW |
|---|---|---|
| Price | $22.74 | $19.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 3 |
| Target Price | ★ $73.11 | $24.67 |
| AVG Volume (30 Days) | ★ 4.0M | 508.5K |
| Earning Date | 02-12-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | N/A | ★ 40.79 |
| EPS | N/A | ★ 0.70 |
| Revenue | $630,598,000.00 | ★ $936,080,000.00 |
| Revenue This Year | $19.68 | $8.70 |
| Revenue Next Year | $19.44 | $7.62 |
| P/E Ratio | ★ N/A | $28.18 |
| Revenue Growth | ★ 20.63 | 7.27 |
| 52 Week Low | $18.41 | $14.21 |
| 52 Week High | $46.50 | $23.49 |
Technical Indicators
Market Signals| Indicator | RARE | OSW |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 35.97 |
| Support Level | $22.40 | $20.57 |
| Resistance Level | $24.65 | $22.36 |
| Average True Range (ATR) | 1.53 | 0.74 |
| MACD | 0.00 | -0.19 |
| Stochastic Oscillator | 64.17 | 12.97 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.